[1]
|
Nebert, D.W. and Russell, D.W. (2002) Clinical Importance of the Cytochromes P450. The Lancet (London, England), 360, 1155-1162. https://doi.org/10.1016/S0140-6736(02)11203-7
|
[2]
|
Zhang, L., Xu, X., Badawy, S., et al. (2020) A Review: Effects of Macrolides on CYP450 Enzymes. Current Drug Metabolism, 21, 928-937. https://doi.org/10.2174/1389200221666200817113920
|
[3]
|
Omura, T. and Sato, R. (1962) A New Cytochrome in Liver Microsomes. The Journal of Biological Chemistry, 237, 1375-1376. https://doi.org/10.1016/S0021-9258(18)60338-2
|
[4]
|
Hu, Y., Xie, S., Xia, H., et al. (2024) The Effect of Shikonin on the Metabolism of Lapatinib in Vitro, and in Vivo. Toxicology and Applied Pharmacology, 482, Article ID: 116797. https://doi.org/10.1016/j.taap.2023.116797
|
[5]
|
Bièche, I., Narjoz, C., Asselah, T., et al. (2007) Reverse Tran-scriptase-PCR Quantification of MRNA Levels from Cytochrome CYP1, CYP2 and CYP3 Families in 22 Different Human Tissues. Pharmacogenetics and Genomics, 17, 731-742. https://doi.org/10.1097/FPC.0b013e32810f2e58
|
[6]
|
Burkina, V., Rasmussen, M.K., Pilipenko, N., et al. (2017) Comparison of Xenobiotic-Metabolising Human, Porcine, Rodent, and Piscine Cytochrome P450. Toxicology, 375, 10-27. https://doi.org/10.1016/j.tox.2016.11.014
|
[7]
|
Zanger, U.M. and Schwab, M. (2013) Cytochrome P450 Enzymes in Drug Metabolism: Regulation of Gene Expression, Enzyme Activities, and Impact of Genetic Variation. Pharmacology & Therapeutics, 138, 103-141.
https://doi.org/10.1016/j.pharmthera.2012.12.007
|
[8]
|
Lewis, D.F. (2004) 57 Varieties: The Human Cytochromes P450. Pharmacogenomics, 5, 305-318.
https://doi.org/10.1517/phgs.5.3.305.29827
|
[9]
|
Ingelman-Sundberg, M. (2004) Pharmacogenetics of Cytochrome P450 and Its Applications in Drug Therapy: The Past, Present and Future. Trends in Pharmacological Sciences, 25, 193-200. https://doi.org/10.1016/j.tips.2004.02.007
|
[10]
|
Li, H. and Wang, H. (2010) Activation of Xenobiotic Re-ceptors: Driving into the Nucleus. Expert Opinion on Drug Metabolism & Toxicology, 6, 409-426. https://doi.org/10.1517/17425251003598886
|
[11]
|
易文杰, 于彤, 樊雪飞, 等. NR4A1与糖尿病的相关性研究[J]. 沈阳医学院学报, 2022, 24(2): 174-177.
|
[12]
|
刘嘉慧, 黄玲, 孙朝晖, 等. 核受体转录因子ERRα在肿瘤发生发展中的研究进展[J]. 重庆医科大学学报, 2023, 48(4): 477-481.
|
[13]
|
徐良, 陶覃龙, 袁杰. 过氧化物酶体增殖物激活型受体α对心血管疾病作用的研究进展[J]. 疑难病杂志, 2015, 14(10): 1081-1084.
|
[14]
|
董月美, 张方, 赵美华, 等. 核受体家族在炎症性肠病中的作用机制[J]. 医学综述, 2019, 25(22): 4369-4373.
|
[15]
|
Borges, L. and Cosman, D. (2000) LIRs/ILTs/MIRs, Inhibitory and Stimulatory Ig-Superfamily Receptors Expressed in Myeloid and Lymphoid Cells. Cytokine & Growth Factor Reviews, 11, 209-217.
https://doi.org/10.1016/S1359-6101(00)00007-1
|
[16]
|
Evans, R.M. and Mangelsdorf, D.J. (2014) Nuclear Recep-tors, RXR, and the Big Bang. Cell, 157, 255-266.
https://doi.org/10.1016/j.cell.2014.03.012
|
[17]
|
Rakateli, L., Huchzermeier, R. and Van Der Vorst, E.P.C. (2023) AhR, PXR and CAR: from Xenobiotic Receptors to Metabolic Sensors. Cells, 12, Article No. 2752. https://doi.org/10.3390/cells12232752
|
[18]
|
Weikum, E.R., Liu, X. and Ortlund, E.A. (2018) The Nuclear Receptor Superfamily: A Structural Perspective. Protein Science: A Publication of the Protein Society, 27, 1876-1892. https://doi.org/10.1002/pro.3496
|
[19]
|
Dahlman-Wright, K., Baumann, H., McEwan, I.J., et al. (1995) Structural Characterization of a Minimal Functional Transactivation Domain from the Human Glucocorticoid Receptor. Proceedings of the National Academy of Sciences of the United States of America, 92, 1699-1703. https://doi.org/10.1073/pnas.92.5.1699
|
[20]
|
Goodwin, B., Jones, S.A., Price, R.R., et al. (2000) A Regulatory Cascade of the Nuclear Receptors FXR, SHP-1, and LRH-1 Represses Bile Acid Biosynthesis. Molecular Cell, 6, 517-526. https://doi.org/10.1016/S1097-2765(00)00051-4
|
[21]
|
Sonoda, J., Pei, L. and Evans, R.M. (2008) Nuclear Receptors: Decoding Metabolic Disease. FEBS Letters, 582, 2-9.
https://doi.org/10.1016/j.febslet.2007.11.016
|
[22]
|
Solt, L.A. and Burris, T.P. (2012) Action of RORs and Their Ligands in (Patho)Physiology. Trends in Endocrinology and Metabolism: TEM, 23, 619-627. https://doi.org/10.1016/j.tem.2012.05.012
|
[23]
|
Kliewer, S.A., Moore, J.T., Wade, L., et al. (1998) An Orphan Nu-clear Receptor Activated by Pregnanes Defines a Novel Steroid Signaling Pathway. Cell, 92, 73-82. https://doi.org/10.1016/S0092-8674(00)80900-9
|
[24]
|
Blumberg, B., Sabbagh, W., Juguilon, H., et al. (1998) SXR, a Novel Steroid and Xenobiotic-Sensing Nuclear Receptor. Genes & Development, 12, 3195-3205. https://doi.org/10.1101/gad.12.20.3195
|
[25]
|
Moore, J.T. and Kliewer, S.A. (2000) Use of the Nuclear Receptor PXR to Predict Drug Interactions. Toxicology, 153, 1-10. https://doi.org/10.1016/S0300-483X(00)00300-0
|
[26]
|
Pondugula, S.R., Dong, H. and Chen, T. (2009) Phosphor-ylation and Protein-Protein Interactions in PXR-Mediated CYP3A Repression. Expert Opinion on Drug Metabolism & Toxicology, 5, 861-873.
https://doi.org/10.1517/17425250903012360
|
[27]
|
Kliewer, S.A., Goodwin, B. and Willson, T.M. (2002) The Nu-clear Pregnane X Receptor: A Key Regulator of Xenobiotic Metabolism. Endocrine Reviews, 23, 687-702. https://doi.org/10.1210/er.2001-0038
|
[28]
|
Chen, C., Staudinger, J.L. and Klaassen, C.D. (2003) Nuclear Receptor, Pregname X Receptor, Is Required for Induction of UDP-Glucuronosyltranferases in Mouse Liver by Pregnenolone-16 Alpha-Carbonitrile. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 31, 908-915. https://doi.org/10.1124/dmd.31.7.908
|
[29]
|
Pavek, P. (2016) Pregnane X Receptor (PXR)-Mediated Gene Repres-sion and Cross-Talk of PXR with Other Nuclear Receptors via Coactivator Interactions. Frontiers in Pharmacology, 7, Article No. 456.
https://doi.org/10.3389/fphar.2016.00456
|
[30]
|
Dong, L., Chen, Q., Liu, X., et al. (2015) Role of Specificity Protein 1, Hepatocyte Nuclear Factor 1α, and Pregnane X Receptor in the Basal and Rifampicin-Induced Transcriptional Regula-tion of Porcine Cytochrome P450 3A46. Drug Metabolism and Disposition: The Biological Fate of Chemicals, 43, 1458-1467.
https://doi.org/10.1124/dmd.115.065565
|
[31]
|
Xu, R., Deng, H., Gan, L., et al. (2022) Chinese Herbal Component, Praeruptorin E, Enhances Anti-Asthma Efficacy and Prevents Toxicity of Aminophylline by Targeting the NF-κB/PXR/CYP3A4 Pathway. Annals of Translational Medicine, 10, Article No. 225. https://doi.org/10.21037/atm-22-386
|
[32]
|
李敏, 张冰, 刘小青. CAMP-PKA信号通路对L02细胞药物代谢酶CYP3A的调控作用[J]. 中国药理学与毒理学杂志, 2011, 25(4): 354-357.
|
[33]
|
Zhang, L., Yan, J., Liu, J., et al. (2022) Panaxytriol Upregulates CYP3A4 Expression Based on the Interaction of PXR, CAR, HSP90α, and RXRα. Phytomedicine: International Journal of Phytotherapy and Phytopharmacology, 101, Article ID: 154097. https://doi.org/10.1016/j.phymed.2022.154097
|
[34]
|
Yan, J., Gu, Q., Meng, C., et al. (2023) Panaxytriol Upregu-lates CYP3A4 Expression through the Interaction between Nuclear Regulators and DNA Response Elements. Journal of Ethnopharmacology, 310, Article ID: 116398.
https://doi.org/10.1016/j.jep.2023.116398
|
[35]
|
Bwayi, M.N., Garcia-Maldonado, E., Chai, S.C., et al. (2022) Mo-lecular Basis of Crosstalk in Nuclear Receptors: Heterodimerization between PXR and CAR and the Implication in Gene Regulation. Nucleic Acids Research, 50, 3254-3275. https://doi.org/10.1093/nar/gkac133
|
[36]
|
Xu, C., Huang, M. and Bi, H. (2016) PXR- and CAR-Mediated Herbal Effect on Human Diseases. Biochimica Et Biophysica Acta, 1859, 1121-1129. https://doi.org/10.1016/j.bbagrm.2016.02.009
|
[37]
|
Yang, H. and Wang, H. (2014) Signaling Control of the Constitutive Androstane Receptor (CAR). Protein & Cell, 5, 113-123. https://doi.org/10.1007/s13238-013-0013-0
|
[38]
|
Yan, J., Chen, B., Lu, J., et al. (2015) Deciphering the Roles of the Constitutive Androstane Receptor in Energy Metabolism. Acta PharmacologicaSinica, 36, 62-70. https://doi.org/10.1038/aps.2014.102
|
[39]
|
Bae, S.D.W., Nguyen, R., Qiao, L., et al. (2021) Role of the Constitutive Androstane Receptor (CAR) in Human Liver Cancer. Biochimica Et Biophysica Acta. Reviews on Cancer, 1875, Article ID: 188516.
https://doi.org/10.1016/j.bbcan.2021.188516
|
[40]
|
Hedrich, W.D., Hassan, H.E. and Wang, H. (2016) Insights into CYP2B6-Mediated Drug-Drug Interactions. Acta Pharmaceutica Sinica B, 6, 413-425. https://doi.org/10.1016/j.apsb.2016.07.016
|
[41]
|
Sueyoshi, T. and Negishi, M. (2001) Phenobarbital Response El-ements of Cytochrome P450 Genes and Nuclear Receptors. Annual Review of Pharmacology and Toxicology, 41, 123-143.
https://doi.org/10.1146/annurev.pharmtox.41.1.123
|
[42]
|
Zelko, I. and Negishi, M. (2000) Phenobarbital-Elicited Activation of Nuclear Receptor CAR in Induction of Cytochrome P450 Genes. Biochemical and Biophysical Research Communications, 277, 1-6.
https://doi.org/10.1006/bbrc.2000.3557
|
[43]
|
Negishi, M., Kobayashi, K., Sakuma, T., et al. (2020) Nuclear Recep-tor Phosphorylation in Xenobiotic Signal Transduction. The Journal of Biological Chemistry, 295, 15210-15225. https://doi.org/10.1074/jbc.REV120.007933
|
[44]
|
关志男, 李赟, 王燕, 等. 青蒿素对孕烷X受体和组成型雄烷受体介导的CYP3A4和CYP2B6转录调节作用[C]//中国药理学会药物代谢专业委员会(CSSX). 第十届全国药物和化学异物代谢学术会议暨第三届国际ISSX/CSSX联合学术会议论文集. 中国药理学会药物代谢专业委员会(CSSX): 中国药理学会, 2012: 2.
|
[45]
|
王燕. 青蒿素类药物通过HPXR和HCAR对CYP3A4和CYP2B6转录调节作用的体外研究[D]: [硕士学位论文]. 太原: 山西医科大学, 2013.
|
[46]
|
Burk, O., Piedade, R., Ghebreghior-ghis, L., et al. (2012) Differential Effects of Clinically Used Derivatives and Metabolites of Artemisinin in the Activation of Constitutive Androstane Receptor Isoforms. British Journal of Pharmacology, 167, 666-681. https://doi.org/10.1111/j.1476-5381.2012.02033.x
|
[47]
|
Mu, Y., Zhang, J., Zhang, S., et al. (2006) Traditional Chi-nese Medicines Wu Wei Zi (Schisandra chinensis Baill) and Gan Cao (Glycyrrhiza uralensis Fisch) Activate Pregnane X Receptor and Increase Warfarin Clearance in Rats. The Journal of Pharmacology and Experimental Therapeutics, 316, 1369-1377. https://doi.org/10.1124/jpet.105.094342
|
[48]
|
Alhusban, M., Pandey, P., Ahn, J., et al. (2022) Compu-tational Tools to Expedite the Identification of Potential PXR Modulators in Complex Natural Product Mixtures: A Case Study with Five Closely Related Licorice Species. ACS Omega, 7, 26824-26843. https://doi.org/10.1021/acsomega.2c03240
|
[49]
|
Haron, M.H., Avula, B., Ali, Z., et al. (2023) Assessment of Herb-Drug Interaction Potential of Five Common Species of Licorice and Their Phytochemical Constituents. Journal of Dietary Supplements, 20, 582-601.
https://doi.org/10.1080/19390211.2022.2050875
|
[50]
|
范岚. 黄芩苷对CYP450代谢酶和药物转运体影响的研究[D]: [博士学位论文]. 长沙: 中南大学, 2008.
|
[51]
|
Li, Y., Wang, Q., Yao, X., et al. (2010) Induction of CYP3A4 and MDR1 Gene Expression by Baicalin, Baicalein, Chlorogenic Acid, and Ginsenoside Rf through Constitutive An-drostane Receptor- and Pregnane X Receptor-Mediated Pathways. European Journal of Pharmacology, 640, 46-54. https://doi.org/10.1016/j.ejphar.2010.05.017
|
[52]
|
Huang, L., Bi, H.C., Liu, Y.H., et al. (2011) CAR-Mediated Up-Regulation of CYP3A4 Expression in LS174T Cells by Chinese Herbal Compounds. Drug Metabolism and Phar-macokinetics, 26, 331-340.
https://doi.org/10.2133/dmpk.DMPK-10-RG-115
|
[53]
|
Liu, Y.H., Mo, S.L., Bi, H.C., et al. (2011) Regulation of Human Pregnane X Receptor and Its Target Gene Cytochrome P450 3A4 by Chinese Herbal Compounds and a Molecu-lar Docking Study. Xenobiotica; the Fate of Foreign Compounds in Biological Systems, 41, 259-280. https://doi.org/10.3109/00498254.2010.537395
|
[54]
|
Qiu, F., Jiang, J., Ma, Y., et al. (2013) Opposite Effects of Single-Dose and Multidose Administration of the Ethanol Extract of Danshen on CYP3A in Healthy Volunteers. Evi-dence-Based Complementary and Alternative Medicine: ECAM, 2013, 730-734. https://doi.org/10.1155/2013/730734
|
[55]
|
Yu, C., Ye, S., Sun, H., et al. (2009) PXR-Mediated Transcriptional Ac-tivation of CYP3A4 by Cryptotanshinone and Tanshinone IIA. Chemico-Biological Interactions, 177, 58-64. https://doi.org/10.1016/j.cbi.2008.08.013
|